kabutan

Fuji Pharma Co.,Ltd., 5% Increase in Ordinary Profit, Record High for The First Time in Eight Years, Dividend to Rise by 3 yen

Tue Nov 12, 2024 4:00 pm JST Earnings

4554 Fuji Pharma Co.,Ltd. 【J-GAAP】

Earnings Report

Fuji Pharma Co.,Ltd. <4554> [TSE-P] announced its financial results after the market closed on November 12th (16:00). The consolidated ordinary profit for the fiscal year ending September 2024 decreased by 1.6% from the previous period to 4.44 billion yen. For the fiscal year ending September 2025, the profit is expected to grow by 5.3% to 4.68 billion yenExpected to reach record high profits for the first time in eight years. This will be the fifth consecutive term of revenue growth.

At the same time, the company has decided to increase the dividend this fiscal year to 45.5 yen, an increase of 3 yen from the previous fiscal year.

In the most recent three-month period, from July to September (4Q), the consolidated ordinary profit decreased to 1.47 billion yen, a 16.9% decrease compared to the same period last year. However, the operating profit margin rose from 12.8% in the same period last year to 12.8%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2022 35,426 3,777 3,725 2,696 111.0 35 Nov 10, 2022 J-GAAP
Sep, 2023 40,889 3,858 4,519 3,435 141.4 37 Nov 9, 2023 J-GAAP
Sep, 2024 46,138 3,880 4,445 6,146 252.9 42.50 Nov 12, 2024 J-GAAP
YoY +12.8% +0.6% -1.6% +78.9% +78.9%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2024 Guidance 46,060 3,990 4,602 6,185 254.4 42.50 May 9, 2024 J-GAAP
Sep, 2024 Results 46,138 3,880 4,445 6,146 252.9 42.50 Nov 12, 2024 J-GAAP
Revision Rate +0.2% -2.8% -3.4% -0.6% -0.6%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 21,388 1,443 2,165 4,257 175.2 20 May 9, 2024 J-GAAP
Oct - Mar, 2024 Guidance 26,150 2,380 2,330 1,650 67.6 20 Nov 12, 2024 J-GAAP
YoY +22.3% +64.9% +7.6% -61.2% -61.4%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Sep, 2023 40,889 3,858 4,519 3,435 141.4 37 Nov 9, 2023 J-GAAP
Sep, 2024 46,138 3,880 4,445 6,146 252.9 42.50 Nov 12, 2024 J-GAAP
Sep, 2025 Guidance 53,360 4,850 4,680 3,380 138.4 45.50 Nov 12, 2024 J-GAAP
YoY +15.7% +25.0% +5.3% -45.0% -45.3%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 11,407 1,455 1,778 1,453 59.8 12.8 Nov 9, 2023 J-GAAP
Oct - Dec, 2023 10,746 -140 -96 2,739 112.7 -1.3 Feb 8, 2024 J-GAAP
Jan - Mar, 2024 10,642 1,583 2,261 1,518 62.5 14.9 May 9, 2024 J-GAAP
Apr - Jun, 2024 11,767 772 802 653 26.9 6.6 Aug 8, 2024 J-GAAP
Jul - Sep, 2024 12,983 1,665 1,478 1,236 50.9 12.8 Nov 12, 2024 J-GAAP
YoY +13.8% +14.4% -16.9% -14.9% -15.0%

Related Articles